Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin, type I cuticular Ha7 (KRT37) is a type I (acidic) hair keratin encoded by the KRT37 gene in humans[3][4]. It belongs to the intermediate filament protein family and is highly expressed in the hair medulla, contributing to the structural integrity of hair[1][3]. KRT37, like other type I hair keratins, forms heterodimers with type II keratins to generate strong fibrous structures in hair and nails[3][1]. Uniquely among keratins, KRT37 is regulated by androgens — a feature specific to humans — and may play a role in patterns of body and scalp hair growth, including possible involvement in androgenic alopecia[4]. Mutations or disruptions in KRT37 have been associated with rare diseases such as blepharocheilodontic syndrome 1 and iron overload in Africa[3]. There are currently no known direct therapeutic drugs targeting KRT37, and it is not generally considered a classical drug target such as a receptor, enzyme, or transporter[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin, type I cuticular Ha7 (KRT37).